Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection

A. M. Gurgo, A. M. Ciccone, A. D'Andrilli, M. Ibrahim, B. Musumeci, G. Quarta, A. Saponaro, E. A. Rendina, M. Volpe

Research output: Contribution to journalArticle

Abstract

Aim. Supraventricular tachyarrhythmias, most frequently atrial fibrillation (AF), occur in 830% of patients undergoing major pulmonary resection. The aim of this study was to characterize a biochemical marker in order to identify subjects at higher risk of postoperative AF. The authors tested the hypothesis that elevated preoperative plasma levels of N-terminal brain-type natriuretic peptide (NT-pro-BNP) may predict the occurrence of postoperative AF. Methods. Fifty-five consecutive patients undergoing elective major thoracic surgery were selected. All patients had 12-lead electrocardiogram and transthoracic echocardiographic evaluation at entry. Plasma NT-pro BNP levels were determined both at baseline and at the first postoperative day. Patients were monitored thereafter to detect the occurrence of AF. For statistical analysis, an unpaired Student t test was used to compare continuous variables, χ2 tests or Fischer exact tests were used for categorical variables, as needed. Results. Eight (14.54%) of the 55 patients developed AF with a peak incidence on postoperative days 2 to 3. Baseline NT-pro-BNP was more than two fold higher in patients who developed AF (506.1±108.4 pg/mL versus 197.7±54.9 pg/mL; P-0.001). Other relevant clinical and diagnostic parameters were not different in the two groups. Patients with NT-pro-BNP level above the median (113.0 pg/mL) had 8-fold increase risk of postoperative AF. Conclusion. A preoperative elevated plasma NT-pro-BNP level was associated with the occurrence of AF in patient undergoing major thoracic surgery. Baseline NT-pro-BNP levels may be proposed as a biochemical marker to detect patients at higher risk of postoperative AF who could benefit from prophylactic therapeutic medication.

Original languageEnglish
Pages (from-to)581-585
Number of pages5
JournalMinerva Cardioangiologica
Volume56
Issue number6
Publication statusPublished - Dec 2008

Fingerprint

Atrial Fibrillation
Lung
Thoracic Surgery
Biomarkers
pro-brain natriuretic peptide (1-76)
Brain Natriuretic Peptide
Tachycardia
Electrocardiography
Students
Incidence

Keywords

  • Atrial fibrillation
  • Natriuretic peptide, brain
  • Pneumonectomy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Gurgo, A. M., Ciccone, A. M., D'Andrilli, A., Ibrahim, M., Musumeci, B., Quarta, G., ... Volpe, M. (2008). Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection. Minerva Cardioangiologica, 56(6), 581-585.

Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection. / Gurgo, A. M.; Ciccone, A. M.; D'Andrilli, A.; Ibrahim, M.; Musumeci, B.; Quarta, G.; Saponaro, A.; Rendina, E. A.; Volpe, M.

In: Minerva Cardioangiologica, Vol. 56, No. 6, 12.2008, p. 581-585.

Research output: Contribution to journalArticle

Gurgo, AM, Ciccone, AM, D'Andrilli, A, Ibrahim, M, Musumeci, B, Quarta, G, Saponaro, A, Rendina, EA & Volpe, M 2008, 'Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection', Minerva Cardioangiologica, vol. 56, no. 6, pp. 581-585.
Gurgo AM, Ciccone AM, D'Andrilli A, Ibrahim M, Musumeci B, Quarta G et al. Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection. Minerva Cardioangiologica. 2008 Dec;56(6):581-585.
Gurgo, A. M. ; Ciccone, A. M. ; D'Andrilli, A. ; Ibrahim, M. ; Musumeci, B. ; Quarta, G. ; Saponaro, A. ; Rendina, E. A. ; Volpe, M. / Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection. In: Minerva Cardioangiologica. 2008 ; Vol. 56, No. 6. pp. 581-585.
@article{99d81602d5894ac3bb9cb330474361c4,
title = "Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection",
abstract = "Aim. Supraventricular tachyarrhythmias, most frequently atrial fibrillation (AF), occur in 830{\%} of patients undergoing major pulmonary resection. The aim of this study was to characterize a biochemical marker in order to identify subjects at higher risk of postoperative AF. The authors tested the hypothesis that elevated preoperative plasma levels of N-terminal brain-type natriuretic peptide (NT-pro-BNP) may predict the occurrence of postoperative AF. Methods. Fifty-five consecutive patients undergoing elective major thoracic surgery were selected. All patients had 12-lead electrocardiogram and transthoracic echocardiographic evaluation at entry. Plasma NT-pro BNP levels were determined both at baseline and at the first postoperative day. Patients were monitored thereafter to detect the occurrence of AF. For statistical analysis, an unpaired Student t test was used to compare continuous variables, χ2 tests or Fischer exact tests were used for categorical variables, as needed. Results. Eight (14.54{\%}) of the 55 patients developed AF with a peak incidence on postoperative days 2 to 3. Baseline NT-pro-BNP was more than two fold higher in patients who developed AF (506.1±108.4 pg/mL versus 197.7±54.9 pg/mL; P-0.001). Other relevant clinical and diagnostic parameters were not different in the two groups. Patients with NT-pro-BNP level above the median (113.0 pg/mL) had 8-fold increase risk of postoperative AF. Conclusion. A preoperative elevated plasma NT-pro-BNP level was associated with the occurrence of AF in patient undergoing major thoracic surgery. Baseline NT-pro-BNP levels may be proposed as a biochemical marker to detect patients at higher risk of postoperative AF who could benefit from prophylactic therapeutic medication.",
keywords = "Atrial fibrillation, Natriuretic peptide, brain, Pneumonectomy",
author = "Gurgo, {A. M.} and Ciccone, {A. M.} and A. D'Andrilli and M. Ibrahim and B. Musumeci and G. Quarta and A. Saponaro and Rendina, {E. A.} and M. Volpe",
year = "2008",
month = "12",
language = "English",
volume = "56",
pages = "581--585",
journal = "Minerva Cardioangiologica",
issn = "0026-4725",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "6",

}

TY - JOUR

T1 - Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection

AU - Gurgo, A. M.

AU - Ciccone, A. M.

AU - D'Andrilli, A.

AU - Ibrahim, M.

AU - Musumeci, B.

AU - Quarta, G.

AU - Saponaro, A.

AU - Rendina, E. A.

AU - Volpe, M.

PY - 2008/12

Y1 - 2008/12

N2 - Aim. Supraventricular tachyarrhythmias, most frequently atrial fibrillation (AF), occur in 830% of patients undergoing major pulmonary resection. The aim of this study was to characterize a biochemical marker in order to identify subjects at higher risk of postoperative AF. The authors tested the hypothesis that elevated preoperative plasma levels of N-terminal brain-type natriuretic peptide (NT-pro-BNP) may predict the occurrence of postoperative AF. Methods. Fifty-five consecutive patients undergoing elective major thoracic surgery were selected. All patients had 12-lead electrocardiogram and transthoracic echocardiographic evaluation at entry. Plasma NT-pro BNP levels were determined both at baseline and at the first postoperative day. Patients were monitored thereafter to detect the occurrence of AF. For statistical analysis, an unpaired Student t test was used to compare continuous variables, χ2 tests or Fischer exact tests were used for categorical variables, as needed. Results. Eight (14.54%) of the 55 patients developed AF with a peak incidence on postoperative days 2 to 3. Baseline NT-pro-BNP was more than two fold higher in patients who developed AF (506.1±108.4 pg/mL versus 197.7±54.9 pg/mL; P-0.001). Other relevant clinical and diagnostic parameters were not different in the two groups. Patients with NT-pro-BNP level above the median (113.0 pg/mL) had 8-fold increase risk of postoperative AF. Conclusion. A preoperative elevated plasma NT-pro-BNP level was associated with the occurrence of AF in patient undergoing major thoracic surgery. Baseline NT-pro-BNP levels may be proposed as a biochemical marker to detect patients at higher risk of postoperative AF who could benefit from prophylactic therapeutic medication.

AB - Aim. Supraventricular tachyarrhythmias, most frequently atrial fibrillation (AF), occur in 830% of patients undergoing major pulmonary resection. The aim of this study was to characterize a biochemical marker in order to identify subjects at higher risk of postoperative AF. The authors tested the hypothesis that elevated preoperative plasma levels of N-terminal brain-type natriuretic peptide (NT-pro-BNP) may predict the occurrence of postoperative AF. Methods. Fifty-five consecutive patients undergoing elective major thoracic surgery were selected. All patients had 12-lead electrocardiogram and transthoracic echocardiographic evaluation at entry. Plasma NT-pro BNP levels were determined both at baseline and at the first postoperative day. Patients were monitored thereafter to detect the occurrence of AF. For statistical analysis, an unpaired Student t test was used to compare continuous variables, χ2 tests or Fischer exact tests were used for categorical variables, as needed. Results. Eight (14.54%) of the 55 patients developed AF with a peak incidence on postoperative days 2 to 3. Baseline NT-pro-BNP was more than two fold higher in patients who developed AF (506.1±108.4 pg/mL versus 197.7±54.9 pg/mL; P-0.001). Other relevant clinical and diagnostic parameters were not different in the two groups. Patients with NT-pro-BNP level above the median (113.0 pg/mL) had 8-fold increase risk of postoperative AF. Conclusion. A preoperative elevated plasma NT-pro-BNP level was associated with the occurrence of AF in patient undergoing major thoracic surgery. Baseline NT-pro-BNP levels may be proposed as a biochemical marker to detect patients at higher risk of postoperative AF who could benefit from prophylactic therapeutic medication.

KW - Atrial fibrillation

KW - Natriuretic peptide, brain

KW - Pneumonectomy

UR - http://www.scopus.com/inward/record.url?scp=59649127748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59649127748&partnerID=8YFLogxK

M3 - Article

C2 - 19092733

AN - SCOPUS:59649127748

VL - 56

SP - 581

EP - 585

JO - Minerva Cardioangiologica

JF - Minerva Cardioangiologica

SN - 0026-4725

IS - 6

ER -